Jeff Ajer
Overview
Jeff Ajer received an average of $4M in total compensation, including $497K in salary, at BioMarin Pharmaceutical from 2012 to 2021.
2021BioMarin PharmaceuticalExecutive Vice President, Chief Commercial Officer
2020BioMarin PharmaceuticalExecutive Vice President, Chief Commercial Officer
2019BioMarin PharmaceuticalExecutive Vice President, Chief Commercial Officer
2018BioMarin PharmaceuticalExecutive Vice President, Chief Commercial Officer
2017BioMarin PharmaceuticalExecutive Vice President, Chief Commercial Officer
2016BioMarin PharmaceuticalExecutive Vice President, Chief Commercial Officer
2015BioMarin PharmaceuticalExecutive Vice President, Chief Commercial Officer
2014BioMarin PharmaceuticalExecutive Vice President, Chief Commercial Officer
2013BioMarin PharmaceuticalExecutive Vice President, Chief Commercial Officer
2012BioMarin PharmaceuticalSenior Vice President, Chief Commercial Officer
Source: SEC filings on April 12, 2022, April 13, 2021, April 14, 2020, April 23, 2019, April 25, 2017, April 25, 2016, and April 23, 2015.
Related executives
We found 11 more executives who work or worked at BioMarin Pharmaceutical.
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
C Guyer
BioMarin Pharmaceutical
Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations
Brian Mueller
BioMarin Pharmaceutical
Chief Financial Officer
Robert Baffi
BioMarin Pharmaceutical
Former President of Global Manufacturing and Technical Operations
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
G Davis
BioMarin Pharmaceutical
General Counsel
Stephen Aselage
BioMarin Pharmaceutical
Executive Vice President & Chief Business Officer
News
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2021 pay rises 1% to $18M
April 12, 2022
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2020 pay slips 2% to $18M
April 13, 2021
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2019 pay rises 18% to $18M
April 14, 2020
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2018 pay slips 2% to $16M
April 23, 2019